The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients

  • E. Lazzeroni
  • I. Olivotto
  • F. Cecchi
  • G. P. Chiriatti
  • A. Sachero
  • G. Renosto
  • Italian Study Group on Cardiomyopathies (SPIC)
Conference paper


The morphological, functional, and genetic abnormalities are heterogeneous in different patient populations with hypertrophie cardiomyopathy (HCM) [1–8]; as a consequence, the natural history and the clinical course are extremely variable and prognostic evaluation is a challenging task in the individual patient.


Hypertrophic Cardiomyopathy NYHA Class Chronic Atrial Fibrillation Prognostic Assessment Left Ventricular Outflow Tract Obstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Frank S, Braunwald E (1968) Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation 37:759–787PubMedCrossRefGoogle Scholar
  2. 2.
    Goodwin JF. (1970) Congestive and hypertrophic cardiomyopathies: a decade of study. Lancet 1:732–739PubMedGoogle Scholar
  3. 3.
    Wigle ED, Sasson Z, Henderson MA, et al. (1985) Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis 28:1–83PubMedCrossRefGoogle Scholar
  4. 4.
    Maron BJ, Spirito P, Wesley Y, Arce J (1986) Development and progression of left ventricular hypertrophy in children with hypertrophie cardiomyopathy. N Engl J Med 315:610–614PubMedCrossRefGoogle Scholar
  5. 5.
    Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780–844PubMedCrossRefGoogle Scholar
  6. 6.
    Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C, (1989) Clinical course and prognosis of hypertrophie cardiomyopathy in an outpatient population. N Engl J Med 320:749–761PubMedCrossRefGoogle Scholar
  7. 7.
    Louie EK, Edwards LC III (1994) Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 36:275–308PubMedCrossRefGoogle Scholar
  8. 8.
    Wigle ED, Rakowski Hypertrophy, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680–1682PubMedCrossRefGoogle Scholar
  9. 9.
    Shah PM, Adelman AG, Wigle ED, et al (1973) The natural (and unnatural) history of hypertrophie obstructive cardiomyopathy. Circ Res 34,35 [Supp1 II]: II179–185Google Scholar
  10. 10.
    Maron BJ, Roberts WC, Epstein SE (1982) Sudden death in hypertrophie cardiomyopathy: profile of 78 patients. Circulation 65:1388–1394PubMedCrossRefGoogle Scholar
  11. 11.
    Swan DA, Bell B, Oakley C, Goodwin J (1971) Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J 33:671–675PubMedCrossRefGoogle Scholar
  12. 12.
    Hardarson T, De La Calzada CS, Curiel JF (1973) Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 2:1462–1464PubMedCrossRefGoogle Scholar
  13. 13.
    Loogen F, Kuhn H, Gietzen F, Losse B, Schulte HD, Bircks W (1983) Clinical course and prognosis of patients with atypical hypertrophic obstructive and hypertrophie nonobstructive cardiomyopathy. Eur Heart J 4 [Suppl. F]:145–151PubMedCrossRefGoogle Scholar
  14. 14.
    Hect GM, Panza JA, Maron BJ (1992) Clinical course of middle-aged asymptomatic patients with hypertrophie cardiomyopathy. Am J Cardiol 69:935–940CrossRefGoogle Scholar
  15. 15.
    McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 59:971–976PubMedCrossRefGoogle Scholar
  16. 16.
    Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE. (1978) “Malignant ” hypertrophie cardiomyopathy: identification of a subgroup of families with unusually frequent premature deaths. Am J Cardiol 41:1133–1140PubMedCrossRefGoogle Scholar
  17. 17.
    Fiddler GI, Tajik AJ, Weidman WH, McGoon DC, Ritter DG, Giuliani ER (1978) Idiopathic hypertrophie subaortic stenosis in the young. Am J Cardiol 42:793–799PubMedCrossRefGoogle Scholar
  18. 18.
    Cecchi F, Maron BJ, Epstein SE (1989) Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after arrest. J Am Coll Cardiol 13:1283–1288PubMedCrossRefGoogle Scholar
  19. 19.
    McKenna WJ, Camm AJ (1989) Sudden death in hypertrophie cardiomyopathy: assessment of patients at high risk. Circulation 80:1489–1494PubMedCrossRefGoogle Scholar
  20. 20.
    Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE (1976) Asymmetric septal hypertrophy in childhood. Circulation 53:9–14PubMedCrossRefGoogle Scholar
  21. 21.
    Shapiro LM, Zezulka A (1983) Hypertrophic cardiomyopathy: a common disease with a good prognosis: five year experience of a district general hospital. Br Heart J 50:530–533PubMedCrossRefGoogle Scholar
  22. 22.
    Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ (1993) Prognosis in hypertrophie cardiomyopathy observed in a large clinic population. Am J Cardiol 72:939–943PubMedCrossRefGoogle Scholar
  23. 23.
    Maron BJ, Spirito P (1993) Impact of patient selection biases on the perception of hypertrophie cardiomyopathy and its natural history. Am J Cardiol 72:970–972PubMedCrossRefGoogle Scholar
  24. 24.
    Spirito P, Rapezzi C, Autore C, et al. (1994) Prognosis of asymptomatic patients with hypertrophie cardiomyopathy and nonsustained ventricular tachicardia. Circulation 90:2743–2747PubMedCrossRefGoogle Scholar
  25. 25.
    Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26:1529–1534PubMedCrossRefGoogle Scholar
  26. 26.
    Cannan CR, Reeder GS, Bailey KR, Melton LJ III, Gersh BJ (1995) Natural history of hypertrophie cardiomyopathy: a population based study, 1976 through 1990. Circulation 92:2488–2495PubMedCrossRefGoogle Scholar
  27. 27.
    Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 11:775–785CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • E. Lazzeroni
  • I. Olivotto
  • F. Cecchi
  • G. P. Chiriatti
  • A. Sachero
  • G. Renosto
  • Italian Study Group on Cardiomyopathies (SPIC)

There are no affiliations available

Personalised recommendations